Nathan Rich
Stock Analyst at Goldman Sachs
(1.02)
# 3,829
Out of 5,072 analysts
84
Total ratings
35.48%
Success rate
-10.16%
Average return
Main Sectors:
Stocks Rated by Nathan Rich
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Maintains: Neutral | $16 → $21 | $18.16 | +15.64% | 6 | May 9, 2024 | |
| ZTS Zoetis | Maintains: Buy | $223 → $196 | $127.69 | +53.50% | 9 | May 6, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $34 → $30 | $11.29 | +165.72% | 8 | May 6, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6.25 → $8 | $12.52 | -36.10% | 7 | May 6, 2024 | |
| NVST Envista Holdings | Maintains: Sell | $20 → $18 | $20.99 | -16.63% | 4 | May 3, 2024 | |
| HUM Humana | Maintains: Buy | $450 → $385 | $245.99 | +56.51% | 7 | Apr 3, 2024 | |
| ELAN Elanco Animal Health | Maintains: Sell | $13 → $14 | $23.31 | -39.94% | 9 | Feb 27, 2024 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Neutral | $10 → $11 | $26.32 | -58.21% | 4 | Feb 5, 2024 | |
| ALGN Align Technology | Maintains: Sell | $197 → $225 | $147.23 | +52.82% | 2 | Feb 2, 2024 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $500 → $650 | $755.96 | -14.02% | 3 | Jan 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $88 | $79.86 | +10.19% | 9 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $19.22 | -37.57% | 6 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $93 → $85 | $75.26 | +12.94% | 1 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $10.64 | +3.38% | 3 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $335 | $148.33 | +125.85% | 1 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $535 | $329.71 | +62.26% | 5 | Dec 14, 2021 |
Oscar Health
May 9, 2024
Maintains: Neutral
Price Target: $16 → $21
Current: $18.16
Upside: +15.64%
Zoetis
May 6, 2024
Maintains: Buy
Price Target: $223 → $196
Current: $127.69
Upside: +53.50%
DENTSPLY SIRONA
May 6, 2024
Maintains: Neutral
Price Target: $34 → $30
Current: $11.29
Upside: +165.72%
Amneal Pharmaceuticals
May 6, 2024
Maintains: Buy
Price Target: $6.25 → $8
Current: $12.52
Upside: -36.10%
Envista Holdings
May 3, 2024
Maintains: Sell
Price Target: $20 → $18
Current: $20.99
Upside: -16.63%
Humana
Apr 3, 2024
Maintains: Buy
Price Target: $450 → $385
Current: $245.99
Upside: +56.51%
Elanco Animal Health
Feb 27, 2024
Maintains: Sell
Price Target: $13 → $14
Current: $23.31
Upside: -39.94%
Teva Pharmaceutical Industries
Feb 5, 2024
Maintains: Neutral
Price Target: $10 → $11
Current: $26.32
Upside: -58.21%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197 → $225
Current: $147.23
Upside: +52.82%
IDEXX Laboratories
Jan 17, 2024
Maintains: Buy
Price Target: $500 → $650
Current: $755.96
Upside: -14.02%
May 4, 2023
Maintains: Buy
Price Target: $100 → $88
Current: $79.86
Upside: +10.19%
Apr 19, 2023
Maintains: Buy
Price Target: $14 → $12
Current: $19.22
Upside: -37.57%
Jul 21, 2022
Downgrades: Neutral
Price Target: $93 → $85
Current: $75.26
Upside: +12.94%
May 12, 2022
Maintains: Neutral
Price Target: $10 → $11
Current: $10.64
Upside: +3.38%
Dec 14, 2021
Initiates: Buy
Price Target: $335
Current: $148.33
Upside: +125.85%
Dec 14, 2021
Initiates: Buy
Price Target: $535
Current: $329.71
Upside: +62.26%